Crossmark

Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models

Crossref DOI link: https://doi.org/10.1186/s12885-017-3917-x

Published Online: 2018-01-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Yanxiu

Zeng, Haoxia

Chang, Xiaohong

Wang, Chaohua

Cui, Heng
More Information

Article History

Received: 17 April 2017

Accepted: 14 December 2017

First Online: 16 January 2018

Ethics approval

: The study was approved by the Institutional Ethics Review Boards of Peking University People’s hospital.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.